IDiyas

For the Inventor, By the Inventor

Sandwich, United Kingdom

Graham Nigel Maw

USPTO Granted Patents = 17

 

Average Co-Inventor Count = 2.3

ph-index = 6

Forward Citations = 256(Granted Patents)


Company Filing History:

goldMedal17 out of 4,455 
 
Pfizer Corporation
 patents

Years Active: 1997-2010

Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents
1. 7649004 - Pyridine derivatives (2010-01-19),
2. 7053122 - Therapeutic use of aryl amino acid derivatives (2006-05-30),
3. 6831074 - Pharmaceutically active compounds (2004-12-14),
4. 6756373 - Pharmaceutically active compounds (2004-06-29),
5. 6734186 - Compounds for the treatment of female sexual dysfunction (2004-05-11),
6. 6593332 - Pharmaceutically active compounds (2003-07-15),
7. 6586439 - Pharmaceutically active compounds (2003-07-01),
8. 6514975 - Anti-inflammatory piperazinyl-benzyl-tetrazole derivatives and intermediates thereof (2003-02-04),
9. 6503908 - Pharmaceutically active compounds (2003-01-07),
10. 6440982 - Pharmaceutically active compounds (2002-08-27),
11. 6333330 - Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexual dysfunction (2001-12-25),
12. 6262046 - Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists (2001-07-17),
13. 6200978 - Compounds as delta opioid agonists (2001-03-13),
14. 5922747 - Indole derivatives as steroid 5.alpha.-reductase inhibitors (1999-07-13),
15. 5912357 - Indole derivatives as 5-.alpha.-reductase-1-inhibitors (1999-06-15),

Title: Graham Nigel Maw: Innovator in Pharmaceutical Chemistry

Introduction

Graham Nigel Maw is a distinguished inventor based in Sandwich, GB. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 17 patents. His work focuses on developing innovative compounds that address various medical conditions.

Latest Patents

Among his latest patents, Graham has developed pyridine derivatives, which relate to compounds that can be used for the treatment of pain. These compounds include pharmaceutically acceptable salts and solvates, along with processes for their preparation and compositions containing them. Another notable patent involves the therapeutic use of aryl amino acid derivatives. These compounds are useful in treating a range of conditions, including faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, neuropathic pain, neuropathological disorders, and sleep disorders. The patents also cover processes for preparing the final products and intermediates, as well as pharmaceutical compositions containing these compounds.

Career Highlights

Graham is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to contribute to the development of groundbreaking therapies that improve patient outcomes.

Collaborations

Graham has collaborated with notable colleagues, including David James Rawson and Julian Blagg. These partnerships have fostered an environment of innovation and creativity in their research endeavors.

Conclusion

Graham Nigel Maw's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…